Telomir Pharmaceuticals, Inc. (TELO)
  • Telomir 1
  • The Science
  • About Us
    • Management
    • Board of Directors
    • Advisors
  • News & Events
  • Investors
  • Contact Us
Select Page

Investor Relations

In the News

Investor relations
  • Overview
  • News & Events
    • Press Releases
    • In the News
    • IR Calendar
    • Presentation
    • Email Alerts
  • Company Info
    • Company Profile
    • Management
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote and Chart
    • Historic Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Results
    • Section 16 Filings
  • GOVERNANCE
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
Aug 16, 2024

ABC7 Exclusive: New study reveals promising results for age reversal pill on dogs

May 9, 2024

Investing In Longevity

Contact Us
  • Follow
  • Follow
  • Follow
  • Telomir 1
  • The Science
  • About Us
    • Management
    • Board of Directors
    • Advisors
  • News & Events
  • Investors
  • Contact Us
  • ADA COMPLIANCE
  • TERMS & CONDITIONS
  • PRIVACY POLICY

© 2024 Telomir Pharmaceuticals. All Rights Reserved. This site is not intended to provide medical advice or to suggest that any product mentioned is safe or efficacious for any disease or condition.

Disclaimer

You are about to review presentations, reports and/or filings of Telomir Pharmaceuticals, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. Telomir Pharmaceuticals, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by Telomir Pharmaceuticals, Inc.

I Accept I Decline

Corporate Governance

Reports Regarding LMP Automotive Holdings’ Accounting or Auditing Matters or Other Concerns and Communications with the Board of Directors.

Shareholders and interested parties may communicate directly with the Board of Directors, the Audit Committee of the Board of Directors with respect to accounting issues, questionable accounting or auditing matters or internal accounting controls, any other Board committee, any individual Director, any group of Directors or the Lead Independent Director by e-mailing [email protected].

Reports may be made anonymously or confidentially.